CS
LIMNW

Clear Street’s Liminatus Pharma Warrants LIMNW Stock Holding History

Clear Street’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$4 – 1492
2026
Q1 		$4 Sell
100
-805,077
-100% -$51.5K ﹤0.01% 1096
2025
Q4 		$28.2K Sell
805,177
-200
-0% -$20 ﹤0.01% 686
2025
Q3 		$119K Sell
805,377
-100
-0% -$20 ﹤0.01% 389
2025
Q2 		$193K Buy
+805,477
New +$158K ﹤0.01% 217

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Clear Street's LIMNW Position: Q2 2026 in Review

Clear Street sold out of Liminatus Pharma Warrants (LIMNW) in Q2 2026, closing a stake of 100 shares — an estimated $4 sold.

Clear Street first reported a position in LIMNW in Q2 2025 and held it in 4 quarters. The position peaked at $193K in Q2 2025. 22 funds tracked by Wall St. Rank hold LIMNW as of Q2 2026.

  • Clear Street reported no remaining Liminatus Pharma Warrants position as of Q2 2026 after selling out during the quarter.
  • Clear Street sold 100 Liminatus Pharma Warrants shares in Q2 2026, an estimated $4.
  • Clear Street first reported a position in Liminatus Pharma Warrants in Q2 2025 and held it in 4 quarters.
  • Clear Street's Liminatus Pharma Warrants position peaked at $193K in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.